Use of grafts procured from organ transplant recipients

Transplantation

Volumn 67, Issue 7, 1999, Pages 1074-1077

  Arvieux, Catherine ^a   Cornforth, Beverley ^b   Gunson, Bridget ^b   Borel, Elizabeth ^a   Letoublon, Christian ^a   McMaster, Paul ^b   Pirenne, Jacques ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; BRAIN DEATH; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

ADULT; BRAIN DEATH; CEREBRAL HEMORRHAGE; CHILD; DATA COLLECTION; FEMALE; GREAT BRITAIN; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS;

EID: 0033561053     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904150-00025     Document Type: Article

References (23)

1. Mirza DF, Gunson BK, Da Silva RF, Mayer AD, Buckels JAC, McMaster P. Policies in Europe on "marginal quality" donor livers. Lancet 1994; 344: 1480.
2. Pasic M, Gallino A, Carrel T, et al. Brief report: reuse of a transplanted heart. N Engl J Med 1993; 328: 15.
3. Moreno Gonzales E, Gomez R, Gonzales Pinto I, et al. Reuse of liver graft after early death of the first recipient. W J of Surg 1996; 20: 309.
4. Adams HP, Dawson G, Coffman TJ, Corry RJ. Stroke in renal transplant recipients. Arch Neurol 1986; 43: 113.
5. Bäckman L, Gibbs J; Levy M, et al. Causes for the late graft loss after liver transplantation. Transplantation 1993; 55: 1078.
6. Dhillon AP, Burroughs AK, Hudson M, Shaii N, Rolles K, Scheuer PJ. Hepatic venular stenosis after orthotopic liver transplantation. Hepatology 1994; 19: 106.
7. Sterneck M, Wiesner R, Asher N, et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991; 14: 806.
8. Ramalho HJ, Terra EG, Cartapatti E, et al. Hepatotoxicity of azathioprine in renal transplant recipients. Transplant Proc 1989; 21: 1716.
9. Wagoner LE, Olsen SL, Bristox MR, et al. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation 1993; 56: 1415.
10. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994; 20: 88.
11. Kowdley KV, Keeffe EB. Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am 1995; 24: 991.
12. Matsumoto T, Yoshimine T, Shimouchi K, et al. The liver in systemic lupus erythematosus- Pathological analysis of 52 cases and review of japanese autopsy registry data. Hum Pathol 1992; 23: 1151.
13. Frenaux E, Pessayre D. Stéatosis, phospholiposes et lésions pseudo-alcooliques hépatiques d'origine médicamenteuse. Gastroenterol Clin Biol 1993; 17: 36.
14. Todo S, Demetris AJ, Makowa LM, et al. Primary non function of hepatic allograft with preexisting fatty infiltration. Transplantation 1989; 47: 903.
15. Pruim J, Klompmaker IJ, Haagsma EB, Bijleveld CMA, Clooff MJII. Selection criteria for poor liver function after orthotopic liver transplantation. Hepatology 1994; 20: 829.
16. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829.
17. Ploeg RJ, d'Alessandro Am, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807.
18. d'Alessandro Am, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies for the development of primary non function after orthotopic liver transplantation. Transplantation 1991; 51: 157.
19. Rush DN. Ciclosporine toxicity to organs other than the kidney. Clin Biochem 1991; 24: 101.
20. Schreibner GF, Flye W, Brunt E, Korber K, Lefkowith JB. Essential fatty acid depletion of renal allograft and prevention of rejection. Science 1988; 240: 1032.
21. Rucker J, Toledo-Pereyra LH, McKenzie GH, Gordon DA. Improvement of kidney transplant survival after graft pretreatment with ciclosporin A. Transplantation 1982; 34: 356.
22. Roak JA. Dentritic cells and the initiation of the immune response to organ transplants. Transplant Rev 1994; 8: 37.
23. Guttman RD, Beaudoin JG, Morehouse DD. Donor pretreatment as an adjunct to cadaver renal allotransplantation. Transplant Proc 1975; 7: 1.